Biotechnology

Abivax Does Not Hold Any Cash or Otherwise Have Any Deposits at SVB or at Any Other U.S. Financial Institution

March 13, 2023 7:15 AM

PARIS, FRANCE / ACCESSWIRE / March 13, 2023 / Abivax SA (the "Company", Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases, is aware that Silicon Valley Bank ("SVB") was closed on March 10, 2023, by the California Department of Financial Protection and Innovation, which appointed the Federal...

Read more

BioInvent Issues Statement Confirming that it does not Hold Cash Deposits or Securities at Silicon Valley Bank

March 13, 2023 3:20 AM

LUND, SWEDEN / ACCESSWIRE / March 13, 2023 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today informed its shareholders that BioInvent does not hold cash deposits or securities at Silicon Valley Bank, or any other foreign bank. In accordance with BioInvent's financial policy, excess...

Read more

Midatech Pharma PLC Announces Further re: Notice of General Meeting

March 10, 2023 1:45 PM

Midatech Pharma PLC ("Midatech" or the "Company") Further re: Notice of General Meeting - Correction of Typographical Errors ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 10, 2023 / Further to the announcement made on 8 March 2023 providing notice of a general meeting (the "GM") of the Company to be held on 24 March 2023, and the publication and despatch of a circular to shareholders containing notice of the resolutions to be considered at the GM...

Read more

SPO Global Inc. Provides Update on Shandong Fangyuan Huizhong Intelligent Equipment Co., Ltd.

March 9, 2023 9:01 AM

SHANDONG, CHINA / ACCESSWIRE / March 9, 2023 / SPO Global Inc. (OTC PINK:SPOM), a healthcare and biotech company, today provides an update on Shandong Fangyuan Huizhong Intelligent Equipment Co., Ltd. Shandong Fangyuan Huizhong Intelligent Equipment Co., Ltd., a leading food machinery company, recently made an exciting announcement regarding their latest venture. Fang Qiang, the general manager of the company, and his team were warmly welcomed...

Read more

Prolocor Announces Appointment of Edward L. Rosen to Its Board of Directors

March 9, 2023 9:00 AM

PHILADELPHIA, PA / ACCESSWIRE / March 9, 2023 / Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by quantifying FcγRIIa on the surface of platelets, today announced that Edward L. Rosen has joined the company's Board of Directors. Rosen is a highly accomplished and well-respected industry expert and has held numerous senior-level positions during his...

Read more

CB Scientific, Inc. Announces Exclusive Canadian Distribution Agreement

March 9, 2023 6:00 AM

Your Heart Protector Corp. to market the Company's products and provide associated monitoring services throughout Canada LAS VEGAS, NV / ACCESSWIRE / March 9, 2023 / CB Scientific. Inc. (OTCQB:CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products and services, today announced that it has finalized a comprehensive distribution agreement with newly formed Your Heart...

Read more

Enalare Therapeutics Nominated for Two Citeline Awards in Recognition of Outstanding Clinical Efforts

March 8, 2023 8:00 AM

PRINCETON, NJ / ACCESSWIRE / March 8, 2023 / Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel compounds for the treatment of life-threatening critical care diseases and community health emergencies, announced today that it has been nominated for two prestigious Citeline Awards sponsored by Informa Pharma Intelligence in recognition of outstanding achievements in clinical research. Enalare is a...

Read more

Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting

March 8, 2023 2:20 AM

Proposed Share Consolidation, Authority to Allot Shares, Disapplication of Pre-Emption Rights, Change of Name, Adoption of New Articles and Cancellation of Admission to Trading on AIM ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 8, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, announces, further to the Company's announcements of 9...

Read more

Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform

March 7, 2023 9:00 AM

Biopharmaceutical research company specializing in cannabis- and plant-inspired medicines shares strategic plan for 2023 and key developments from 2022 LAS VEGAS, NV / ACCESSWIRE / March 7, 2023 / Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, issued a letter to shareholders today from President, Chief Science Officer, and Director Dr. Andrea Small-Howard and Chairman...

Read more

Form Bio Names Linda Murray as Chief Financial Officer

March 3, 2023 9:00 AM

Senior executive brings deep financial planning and analysis experience to leadership team. DALLAS / ACCESSWIRE / March 3, 2023 / Form Bio, the breakthrough computational life sciences platform, today announced the appointment of Linda Murray as Chief Financial Officer. "We are excited to announce this important addition to Form Bio's leadership team as we enter an exciting time in our development and evolution; we're growing rapidly as more...

Read more

enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

March 2, 2023 5:15 PM

- Achieved more than half of enrollment in U.S. SAVVE pivotal trial of VenoValve® in 2022 - Multiple near-term milestones expected across VenoValve® and enVVe™ clinical programs - Ended the year with $39.1 million in cash and investments including $3.6 million burn for Q4 - Cash expected to support operations through the end of 2024, including release of SAVVE topline data and TAVVE first-in-human study data IRVINE, CA / ACCESSWIRE / March 2,...

Read more

Lexaria's DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels

March 2, 2023 8:45 AM

KELOWNA, BC / ACCESSWIRE / March 2, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that its diabetes animal model study DIAB-A22-1 has completed and produced at least three positive outcomes including weight loss in obese diabetic-conditioned animals, together with improved triglyceride and cholesterol levels. REDUCED BODY WEIGHT Beginning just...

Read more

Celcuity to Participate in Cowen's 43rd Annual Health Care Conference

March 1, 2023 8:00 AM

MINNEAPOLIS, MN / ACCESSWIRE / March 1, 2023 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced its participation in Cowen's 43rd Annual Health Care Conference to be held in Boston on March 6-8, 2023. Brian Sullivan, Chief Executive Officer and co-founder of Celcuity, is scheduled to present at 11:10 a.m. ET on Wednesday, March 8, 2023. A live webcast...

Read more

BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Laboratories

February 28, 2023 3:00 PM

BIRMINGHAM, AL / ACCESSWIRE / February 28, 2023 / BioGX, a global provider of easy molecular diagnostic solutions since 2007, has announced fulfillment of multiple initial orders for its portable pixl™ real-time PCR platform to customers across the U.S., with immediate plans to scale production to meet market demand. "We're very impressed with the response to the launch of our novel 'pixl' qPCR platform. Pixl is accelerating validation and...

Read more

Nascent Announces the Completion of Its Phase1 Clinical Trials

February 28, 2023 8:00 AM

NORTH PALM BEACH, FL / ACCESSWIRE / February 28, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company whose business is focused in the brain cancer space, announced today that the Company has completed and closed its Phase I clinical trial evaluating safety and tolerance for Pritumumab ("PTB") as a treatment for Primary and Metastatic Brain Cancers. Previous...

Read more

Enzolytics, Inc. Highlights Plans for Promotion of IPF Immune(TM), Its Patented Nutraceutical Supplement

February 28, 2023 7:00 AM

COLLEGE STATION, TX / ACCESSWIRE / February 28, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Enzolytics, Inc. has completed the onboarding process on Amazon (www.amazon.com) for its IPF Immune™ nutritional supplement, permitting the direct sale and distribution of IPF Immune through the Amazon platform. Enzolytics' direct seller account with Amazon allows the Company to benefit from substantial margins and promotional...

Read more

Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights

February 28, 2023 2:00 AM

Total Voting Rights LONDON, UK / ACCESSWIRE / February 28, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the Company as at 28 February 2022 consists of 1,141,999,321 ordinary shares of 1 pence each, none of which are held in treasury. Therefore, the total number of voting rights in the Company is...

Read more

Mushrooms Inc. (OTC: MSRM) Announces Plan for Acquisitions and Vertically Integrated Business Development by Partnering with diversified Mushroom Market Leaders

February 23, 2023 8:00 AM

ESTERO, FL / ACCESSWIRE / February 23, 2023 / Mushrooms, Inc. (OTC PINK:MSRM) (the "Company") has been quietly making progress within this exciting multi-billion-dollar market opportunity currently being opened by new mycelium-based materials science and biotechnology. Mushrooms Inc. is developing profitable pathways to sustain the research and development branch which is necessary to achieve viable industrial innovation in this new field. MSRM...

Read more

Adolore Biotherapeutics to Present Its Gene Therapy Program for Chronic Pain at the 4th Annual National Institutes of Health (NIH) HEAL Initiative Investigator Meeting

February 22, 2023 9:00 AM

DELRAY BEACH, FL / ACCESSWIRE / February 22, 2023 / Adolore Biotherapeutics, Inc. ("Adolore" or the "Company") a biotechnology company focused on developing breakthrough opioid-free pain relieving (analgesic) treatments for pain, today announced that Dr. Roy C. Levitt, the Company's founder, and Executive Chairman, will present at the 4th Annual NIH HEAL Initiative Investigator Meeting taking place February 21-22, 2023. The NIH HEAL (Helping to...

Read more

BioInvent International AB Year-End Report January 1 - December 31, 2022

February 22, 2023 2:20 AM

LUND, SWEDEN / ACCESSWIRE / February 22, 2023 / BioInvent International (STO:BINV) "BioInvent made significant advances in 2022, further developing our exciting pipeline of novel and first-in-class immuno-modulatory antibodies for cancer therapy and substantially reinforcing the company's financial position." - Martin Welschof, CEO of BioInvent. Events in the fourth quarter Phase 1 trial with subcutaneous formulation of BI-1206 initiated Notice...

Read more